Page 2 - Best oncologists in Spain: TOP 44 doctors

Professor Felip leads thoracic cancer trials at Hospital Quiron Barcelona, specializing in lung cancer with over 900 procedures performed.

• 39 years of experience of experience in oncology
• Pioneers new pharmacogenomic and immunotherapy approaches
• Member of ESMO, ASCO, and IASLC leadership
• Received ESMO Women for Oncology Award

Key facts and achievements

• - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases.
• -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care.
• - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris.

Specialization

• More than 7,000 patients have been treated in the Radiosurgery Department, including:
• - Benign tumors : meningiomas, schwannomas, pituitary adenomas.
• - Malignant pathologies : brain metastases and CNS tumors.
• - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas.
• - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder.

Scientific and professional activities

• - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh .
• - Author of scientific research and protocols for the treatment of cancer using radiotherapy.
• - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research.

Experience

2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.

2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.

2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid

Qualification

2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain

2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.

1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.

2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.

1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"

1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"

1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"

1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.

Teaching :

2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.

2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.

2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.

2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.

2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.

2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.

1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).

Publications

2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.

2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047

2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.

2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.

2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.

Presentations

2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.

2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018

2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.

2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia

2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.

Communities it belongs to:

-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)

-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"

-SSRI, International Society for Stereotactic Radiosurgery

- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).

Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Expert in personalized cancer therapies and immunotherapy with 76 years of experience of oncology practice – leads groundbreaking treatments at Quironsalud Torrevieja.

• Pioneered autologous bone marrow transplants and high-dose chemotherapy
• Specializes in RNA microarrays and pharmacogenomics for tailored treatments
• Advanced fellowship in immunotherapy at Cleveland Clinic
• Published 120+ papers on cancer research
• Member of AACR, ASCO, and ASH

36 years of experience leading oncology departments at major Spanish hospitals – Dr. Joseba Rebollo Liceaga specializes in multidisciplinary cancer care at Quironsalud Torrevieja.

• Specialized in Medical Oncology at Clínica Universidad de Navarra
• Published research on innovative treatments like electrochemotherapy
• Former Head of Oncology at multiple prestigious hospitals
• Teaches future oncologists as former university associate physician

Pioneered diagnostic criteria for paraneoplastic neurological syndromes – Dr. Graus is a leading figure in neuro-oncology at Hospital Quiron Barcelona.

• Founder and past president of the European Association of Neuro-Oncology
• Specializes in gliomas, brain lymphomas, and treatment-related neurotoxicities
• Trained in neuro-oncology at Memorial Sloan-Kettering Cancer Center
• Former Chief of Neurology at Hospital Clinic Barcelona
• Honored with Doctor Honoris Causa by Lyon University

15,000+ surgical procedures performed – Dr. de Lacy is a pioneer in minimally invasive techniques for colon and rectal cancer at Hospital Quiron Barcelona.

• Performs 1,000+ interventions annually using laparoscopic and robotic methods
• World-renowned pioneer in gastrointestinal surgery techniques
• President of the Association of Surgeons-Endoscopists in Europe
• Founder of TaTME technique for rectal cancer surgery

Pediatric orthopedist-traumatologist, specializes in surgical oncology

15 years of experience

• 
  
• He passed specialization in orthopedic surgery and traumatology at the Children's Research Hospital of St. Jude in Memphis, USA (2007-2008).
• Dr. Thorner Rubins currently teaches at the University of Barcelona.
• Нe is the head of the Department of Orthopedics and Traumatology at the Hospital Sant Joan de Déu in Barcelona.

Specialist in retinoblastoma treatment at SJD Barcelona Children's Hospital – a leading center for pediatric oncology.

• Focuses exclusively on pediatric eye cancers
• Works at one of Europe's top children's hospitals
• Expert in cutting-edge treatments for retinoblastoma

Professor Bosch is a globally recognized leader in Chronic Lymphocytic Leukemia (CLL), pioneering new treatments and diagnostic technologies.

• Leads 80+ clinical trials from phase 1 to phase 3
• Head of Hematology at Vall d'Hebron University Hospital
• Published 100+ articles in top medical journals
• Specializes in molecular pathogenesis of CLL
• President of Spanish CLL study group (GELLC)

Principal Investigator in multiple clinical trials for ovarian, cervical, and endometrial cancer – Dr. Oaknin brings advanced research directly to patient care.

• Leading expert in angiogenesis and DNA repair for gynecological cancers
• Author of 100+ publications and presentations in oncology
• Co-Chair of GEICO, Spain's ovarian cancer research group
• Faculty member for Gyn-Track in ESMO and ASCO member

Dr. Soberino has contributed to pivotal trials that revolutionized melanoma treatment with drugs like Pembrolizumab and Nivolumab.

• Specializes in immunotherapy for melanoma at Hospital Quiron Barcelona
• Key participant in trials leading to FDA-approved drugs
• Member of Vall d’Hebron’s Melanoma Unit, a leading oncology center
• Focuses on overcoming hormone therapy resistance in breast cancer

Dr. Prat leads SOLTI's clinical trials, focusing on gene expression and molecular subtypes of breast cancer. His research translates directly into personalized treatment approaches.

• Head of Translational Genomics at IDIBAPS – integrates lab findings into patient care
• President of SOLTI – designs novel breast cancer treatments
• Holds three patents in breast cancer diagnostics
• Over 160 publications with 13,479 citations
• Tenure-track professor at Barcelona University

Dr. Joan Albanell Mestres leads the breast cancer program at HM Delfos, with over 37 years of experience of experience and 120+ published articles in oncology.

• Specializes in breast cancer treatment and research
• Head of Oncology services at Clin del Mar
• Conducted groundbreaking research on telomerase in New York
• Leading member of GEICAM, CIBERONC, AIECA, and SEOM
• Director of cancer research program at Del Mar

Dr. Lopez Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe with over 32 years of experience dedicated to childhood cancers.

• Specialized in bone and brain tumors, leukemia, and hematological diseases
• Trained in Pediatric Hematology and Oncology at the University of Maryland
• Author of numerous national and international scientific publications
• Previously directed pediatric oncology at Clínica San Rafael

Director of postgraduate research in clinical and applied oncology – Dr. Cubillo Gracián trains future specialists at HM CIOCC while treating digestive system cancers.

• Specializes in digestive neoplasms and pancreatic neuroendocrine tumors
• Teaches oncology courses at USP CEU university
• Trained at MD Anderson Cancer Center
• Leads international courses on digestive system pathology

140+ published articles on urological cancers – Dr. Mellado Gonzalez leads translational research at Hospital Clínic de Barcelona's IDIBAPS institute.

• Specializes in prostate, kidney, bladder, and testicular cancers
• Principal investigator for multiple clinical trials on new therapies
• Associate Professor at University of Barcelona's Faculty of Medicine
• Teaches uro-oncology at master's level and supervises doctoral theses